1-4 of 4
Javier Bordone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Florencia Negri Aranguren, MD, Santiago Cranco, Claudia Shanley, MD, Isolda I. Fernandez, MD, Maria Virginia Prates, MD, Victoria Otero, Lorena Fiad, Maria Cecilia Foncuberta, MD, Marcela Miodosky, MD, Miguel A. Pavlovsky, MD, Gustavo Kuminsky, Javier Bordone, Bruno Wannesson, Ariel Corso Corso, Dardo Riveros, MD, Marisa Marquez, MD, Gustavo Jarchum, MD, Maria Sol Jarchum, Ider Ramon Cerutti, MD, Alicia Bistmas, Monica Tamashiro, MD, Giselda De Stefano, Alicia Navieckas, Silvana Cugliari, MD, Pedro Negri Aranguren, MD, Gabriela Balaguer, Maria Tosin, Guillermina Remaggi, Juan Altuve, Juan Jose Garcia, MD, Luciana C. Ferrari, MD, Graciela Klein, Luciana Guanchiale, Luis Beligoy, MD, Mariana Marull, Maria Cecilia Dacunto, Marta Elisa Zerga, MD, Nicolas Matias Kurgansky, MD, Marcelo Pujol, MD, Rossana L. Taus, MD PhD, Federico Sackman, MD PhD, Veronica Cintia Canosa, Soledad Cruset, Maximiliano Riddick, Astrid Pavlovsky, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4089.
https://doi.org/10.1182/blood.V130.Suppl_1.4089.4089
Published: 2017
Journal Articles

90 y-Ibritumomab Tiuxetan Treatment for Relapsed and/or Refractory B-Cell Non- Hodgkin’S Lymphoma. Multi-Institutional Argentinian Study. An Update

Roberto Cacchione, MD, Jorge Milone, MD, Javier Bordone, MD, Elsa Nucifora, MD, Juan Dupont, MD, Guy Garay, Dardo Riveros, Alfredo Basso, MD, Silvia Rudoy, MD, Gustavo Milone, MD, Luis Palmer, MD, Daniel Argentieri, MD, Alicia Trouboul, MD, Maria Ardaiz, MD, Marcelo Iabstrebner, MD, Gonzalo Pombo, MD, Alicia Diaz, MD, Roberto Tur, MD, Carlos Chiattone, MD, Hugo Krupitzki, MD, Diana Lafalce, MD, Hugo Corradini, Mario Brown Arnold, MD, Carlos Cañellas, PHD, Marta Zerga, MD, Antonio Carrasco, MD, Fernando Bezares, MD
Journal: Blood
Blood (2008) 112 (11): 5009.
https://doi.org/10.1182/blood.V112.11.5009.5009
Published: 2008
Journal Articles

90 Y-Ibritumomab Treatment for Relapsed and/or Refractory B Cell Type Non-Hodgkin’s Lymphoma. Multiinstitutional Argentinian Study.

Roberto Cacchione, MD, Juan Dupont, MD, Jorge Milone, MD, Javier Bordone, MD, Guy Garay, MD, Maria Ardaiz, MD, Miguel Castro-Rios, MD, Virginia Prates, MD, Alfredo Basso, MD, Marcelo Iabstrebner, MD, Graciela Avila, MD, Alicia Diaz, MD, Daniel Argentieri, MD, Silvia Rudoy, MD, Alicia Trouboul, MD, Luis Palmer, MD, Gonzalo Pombo, MD, Silvina Rappaciotti, MD, Pedro Negri, MD, Diana Lafalse, MD, Leandro Riera, MD, Miguel de Tezanos-Pinto, MD, Dardo Riveros, MD, Mario Brown Arnold, MD, Antonio Carrasco, MD, Fernando Bezares, MD
Journal: Blood
Blood (2007) 110 (11): 4484.
https://doi.org/10.1182/blood.V110.11.4484.4484
Published: 2007
Journal Articles

A Phase 2 Study of 90 Y-Ibritumomab Tiuxetan ( 90 Y-Zevalin®) in Relapsed/Refractory Non-Hodgkin’s Lymphoma: Preliminary Report of the Argentinean Cooperative Group.

Roberto E. Cacchione, MD, Jorge Milone, Javier Bordone, Juan Dupont, Gustavo Milone, Dardo Riveros, Pedro Negri, María Ardaiz, Leandro Riera, Maria Cecilia Foncuberta, Fernando Bezares
Journal: Blood
Blood (2006) 108 (11): 4688.
https://doi.org/10.1182/blood.V108.11.4688.4688
Published: 2006